Surface treatment of implant materials with antimicrobial nanoparticulates

Gen Dent. 2018 Jan-Feb;66(1):66-73.

Abstract

This study analyzed nanostructured silver vanadate (AgVO3) films on certain substrate surfaces found in dental implant devices in order to see if these films promote antimicrobial activity. Enamel and glaze vehicles were used to apply the nanomaterial (0.0% [control], 2.5%, 5.0%, and 10.0% concentrations) on 3 substrates (280 specimens per substrate): polytetrafluoroethylene (PTFE), polyacetal, and acrylic resin. An agar diffusion method was performed in triplicate to determine the antimicrobial activity against 8 microorganisms. Physical behavior and morphologic properties were also analyzed. The growth of Pseudomonas aeruginosa, Escherichia coli, Streptococcus mutans, Enterococcus faecalis, and Staphylococcus aureus was inhibited with the application of AgVO3. For Candida albicans, Porphyromonas gingivalis, and Prevotella intermedia, no antimicrobial activity was observed. Except for S mutans, the type of substrate did not influence the microbiologic results. The glaze showed greater antimicrobial efficacy against S aureus, E faecalis, and S mutans than did the enamel vehicle (P < 0.05). Films with 10% AgVO3 showed greater antimicrobial activity (P < 0.05). The choice of substrate or vehicle did not influence the surface roughness (P > 0.05); however, the application of 10% AgVO3 caused greater surface change (P < 0.05). The application of the nanomaterial did not influence the surface hardness of substrates when compared with the control group (P > 0.05). The use of the glaze as a vehicle provided higher hardness values (P < 0.05).

Keywords: antimicrobial products; dental prosthesis; implant-supported; nanotechnology; physical properties.

MeSH terms

  • Anti-Infective Agents / administration & dosage
  • Anti-Infective Agents / pharmacology
  • Anti-Infective Agents / therapeutic use*
  • Candida albicans / drug effects
  • Dental Implants*
  • Disk Diffusion Antimicrobial Tests
  • Enterococcus faecalis / drug effects
  • Escherichia coli / drug effects
  • Humans
  • Metal Nanoparticles / administration & dosage
  • Metal Nanoparticles / therapeutic use*
  • Porphyromonas gingivalis / drug effects
  • Prevotella intermedia / drug effects
  • Pseudomonas aeruginosa / drug effects
  • Silver Compounds / administration & dosage
  • Silver Compounds / pharmacology
  • Staphylococcus aureus / drug effects
  • Streptococcus mutans / drug effects
  • Vanadates / administration & dosage
  • Vanadates / pharmacology

Substances

  • Anti-Infective Agents
  • Dental Implants
  • Silver Compounds
  • Vanadates